Pediatrix Medical (MD) Enterprise Value (2009 - 2026)

Pediatrix Medical has disclosed Enterprise Value across 18 years of filings, most recently posting -$329.0 million for Q1 2026.

• In Q1 2026, Enterprise Value fell 50.1% year-over-year to -$329.0 million; the TTM figure through Mar 2026 stood at -$329.0 million (down 50.1% YoY), while the FY2025 annual figure was -$499.7 million, down 43.39% from the prior year.
• Enterprise Value grew to -$329.0 million in Q1 2026, from -$499.7 million in the prior quarter.
• Over the last five years, Enterprise Value for MD reached as high as -$96.8 million in Q1 2022 and fell as low as -$499.7 million in Q4 2025.
• The 5-year median for Enterprise Value is -$133.2 million (2024), against an average of -$211.4 million.
• Annual changes were most pronounced in 2022 — Enterprise Value jumped 78.83% — and 2025, when it sank 161.51%.
• A 5-year view of Enterprise Value shows it stood at -$103.1 million in 2022, then slumped by 72.46% to -$177.7 million in 2023, then slumped by 96.07% to -$348.5 million in 2024, then plunged by 43.39% to -$499.7 million in 2025, then soared by 34.17% to -$329.0 million in 2026.
• According to Business Quant data, Enterprise Value over the past three periods registered -$329.0 million, -$499.7 million, and -$463.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.